On 11 May 2015, dealmakers and investors from the international biopharmaceutical industry will come together in Munich to discover the most promising life-science technologies as licensing or investment opportunities.
Top scientists from about 50 research institutes in 10 European nations and their technology transfer partners will present some 50 patent-protected technologies with strong commercial prospects: potential diagnostics and therapeutics as well as platform technologies. In addition, BioVaria’s Spin-off Panel will feature some of Europe’s most innovative start-ups.
Find out more about the programme at: http://www.biovaria.org